Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C

by Bougen, N.M., Yang, T., Chen, H., Lobie, P.E., Perry, J.K.
Published 2014

Growth hormone and cancer: An update on progress

by Perry, J.K., Liu, D.-X., Wu, Z.-S., Zhu, T., Lobie, P.E.
Published 2014

The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells

by Hou, L., Xu, B., Mohankumar, K.M., Goffin, V., Perry, J.K., Lobie, P.E., Liu, D.-X.
Published 2014

Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells

by Bougen, N.M., Steiner, M., Pertziger, M., Banerjee, A., Brunet-Dunand, S.E., Zhu, T., Lobie, P.E., Perry, J.K.
Published 2014

The GDNF Family: a Role in Cancer?

by Fielder, G.C., Yang, T.W.-S., Razdan, M., Li, Y., Lu, J., Perry, J.K., Lobie, P.E., Liu, D.-X.
Published 2022

Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma

by Wu, Z.-S., Yang, K., Wan, Y., Qian, P.-X., Perry, J.K., Chiesa, J., Mertani, H.C., Zhu, T., Lobie, P.E.
Published 2014

Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis

by Bougen, N.M., Amiry, N., Yuan, Y., Kong, X.J., Pandey, V., Vidal, L.J.P., Perry, J.K., Zhu, T., Lobie, P.E.
Published 2014

STAT3α is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone

by Tang, J.-Z., Kong, X.-J., Banerjee, A., Muniraj, N., Pandey, V., Steiner, M., Perry, J.K., Zhu, T., Liu, D.-X., Lobie, P.E.
Published 2014

Autocrine/paracrine human growth hormone-stimulated microRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer

by Zhang, W., Qian, P., Zhang, X., Zhang, M., Wang, H., Wu, M., Kong, X., Tan, S., Ding, K., Perry, J.K., Wu, Z., Cao, Y., Lobie, P.E., Zhu, T.
Published 2016

Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma

by Kong, X, Wu, W, Yuan, Y, Pandey, V, Wu, Z, Lu, X, Zhang, W, Chen, Y, Wu, M, Zhang, M, Li, G, Tan, S, Qian, P, Perry, J.K, Lobie, P.E, Zhu, T
Published 2020

Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma

by Kannan, N., Kang, I., Kong, X., Tang, J., Perry, J.K., Mohankumar, K.M., Miller, L.D., Liu, E.T., Mertani, H.C., Zhu, T., Grandison, P.M., Liu, D.-X., Lobie, P.E.
Published 2014

SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy

by Jung, Y., Abdel-Fatah, T.M.A., Chan, S.Y.T., Nolan, C.C., Green, A.R., Ellis, I.O., Li, L., Huang, B., Lu, J., Xu, B., Chen, L., Ma, R.Z., Zhang, M., Wang, J., Wu, Z., Zhu, T., Perry, J.K., Lobie, P.E., Liu, D.-X.
Published 2014